PuraPharm Updates Board Composition and Committee Assignments

Bulletin Express
04/27

PuraPharm Corporation Limited released an updated list of directors and their respective roles as of 27 April 2026.

The Board now comprises nine members: • Executive Directors: Mr. Chan Yu Ling, Abraham (Chairman); Ms. Man Yee Wai, Viola; Dr. Tsoi Kam Biu, Alvin. • Non-executive Directors: Mr. Leung Stephen Kwok Keung; Mr. Dong Zimeng. • Independent Non-executive Directors: Dr. Hung Ting On, John; Dr. Leung Lim Kin, Simon; Prof. Tsui Lap Chee; Mr. Lee Stephen; Prof. Ng Wang Wai Charles.

Committee structure highlights: 1. Audit Committee – Chair: Dr. Hung Ting On, John – Members: Dr. Leung Lim Kin, Simon; Prof. Tsui Lap Chee; Mr. Lee Stephen; Prof. Ng Wang Wai Charles

2. Remuneration Committee – Chair: Dr. Leung Lim Kin, Simon – Members: Dr. Hung Ting On, John; Prof. Tsui Lap Chee; Mr. Lee Stephen; Prof. Ng Wang Wai Charles

3. Nomination Committee – Chair: Mr. Chan Yu Ling, Abraham – Members: Ms. Man Yee Wai, Viola; Dr. Hung Ting On, John; Dr. Leung Lim Kin, Simon; Prof. Tsui Lap Chee; Mr. Lee Stephen; Prof. Ng Wang Wai Charles

The announcement affirms that independent non-executive directors occupy all chair positions for the Audit and Remuneration Committees, underscoring board independence, while the Nomination Committee is chaired by the company’s executive chairman.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10